Unlike reports that are 'dead on arrival' nm|OK is a constantly updated comprehensive report on every aspect of oncology drug development. To replace nm|OK as a resource in staying informed in this sector you would need to acquire 100s of reports for thousands of dollars only to discard them as they become dated. With nm|OK you have access to a a dynamic resource for only pennies per record.

• compare results of clinical trials of drugs sharing common parameters (target, origin, drug delivery, etc.) in terms of patient/tumor profile, toxicity, response, survival, etc.


• compare protocols and interim and final results of clinical trials by specific indication (triple negative breast cancer, soft tissue sarcoma, mantle cell lymphoma, glioblastoma multiforme) by disease stage and by treatment (first line, refractory, combination regimen, adjuvant, neoadjuvant, etc.), etc.